Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alkermes (ALKS) Capital Expenditures (2016 - 2025)

Alkermes (ALKS) has disclosed Capital Expenditures for 16 consecutive years, with -$20000.0 as the latest value for Q4 2025.

  • Quarterly Capital Expenditures fell 100.2% to -$20000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $40.4 million through Dec 2025, up 20.71% year-over-year, with the annual reading at $40.4 million for FY2025, 20.71% up from the prior year.
  • Capital Expenditures for Q4 2025 was -$20000.0 at Alkermes, down from $17.3 million in the prior quarter.
  • The five-year high for Capital Expenditures was $17.3 million in Q3 2025, with the low at -$20000.0 in Q4 2025.
  • Average Capital Expenditures over 5 years is $9.4 million, with a median of $9.2 million recorded in 2021.
  • The sharpest move saw Capital Expenditures soared 117.62% in 2022, then crashed 100.2% in 2025.
  • Over 5 years, Capital Expenditures stood at $8.7 million in 2021, then grew by 15.78% to $10.0 million in 2022, then soared by 69.82% to $17.0 million in 2023, then plummeted by 42.61% to $9.8 million in 2024, then crashed by 100.2% to -$20000.0 in 2025.
  • According to Business Quant data, Capital Expenditures over the past three periods came in at -$20000.0, $17.3 million, and $13.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.